The safety dance: Biophysics of membrane protein folding and misfolding in a cellular context

Quarterly Reviews of Biophysics

Volumn 44, Issue 3, 2014, Pages 1-34

  Schlebach, Jonathan P ^a   Sanders, Charles R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; CELLS; CHEMISTRY; HOMEOSTASIS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANIMALS; CELLS; HOMEOSTASIS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT;

EID: 84923958655     PISSN: 00335835     EISSN: 14698994     Source Type: Journal    
DOI: 10.1017/S0033583514000110     Document Type: Article

References (261)

1. ADAMIAN, L. & LIANG, J. (2002). Interhelical hydrogen bonds and spatial motifs in membrane proteins: Polar clamps and serine zippers. Proteins 47(2), 209-218.
2. ALLEN, S., CURRAN, A., TEMPLER, R., MEIJBERG, W. & BOOTH, P. (2004). Controlling the folding efficiency of an integral membrane protein. Journal of Molecular Biology 342(4), 1293-1304.
3. ALLEN, S., CURRAN, A., TEMPLER, R., MEIJBERG, W. & BOOTH, P. (2004). Folding kinetics of an alpha helical membrane protein in phospholipid bilayer vesicles. Journal of Molecular Biology 342(4), 1279-1291.
4. ANFINSEN, C. B. (1973). Principles that govern the folding of protein chains. Science 181(4096), 223-230.
5. BAKER, R.P. & URBAN, S. (2012). Architectural and thermodynamic principles underlying intramembrane protease function. Nature Chemical Biology 8(9), 759-768.
6. BALCH, W. E., MORIMOTO, R. I., DILLIN, A. & KELLY, J.W. (2008). Adapting proteostasis for disease intervention. Science 319(5865), 916-919.
7. BARRERA, F. N., RENART, M. L., POVEDA, J. A., DE KRUIJFF, B., KILLIAN, J.A. & GONZ'LEZ-ROS, J.M. (2008). Protein selfassembly and lipid binding in the folding of the potassium channel KcsA. Biochemistry 47(7), 2123-2133.
8. BAYLE, D., WEEKS, D. & SACHS, G. (1995). The membrane topology of the rat sarcoplasmic and endoplasmic reticulum calcium ATPases by in vitro translation scanning. Journal of Biological Chemistry 270(43), 25678-25684.
9. BENCE, N. F., SAMPAT, R.M. & KOPITO, R. R. (2001). Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292(5521), 1552-1555.
10. BERK, J. L., SUHR, O. B., OBICI, L., SEKIJIMA, Y., ZELDENRUST, S. R., YAMASHITA, T., HENEGHAN, M. A., GOREVIC, P. D., LITCHY, W. J., WIESMAN, J. F., NORDH, E., CORATO, M., LOZZA, A., CORTESE, A., ROBINSON-PAPP, J., COLTON, T., RYBIN, D. V., BISBEE, A. B., ANDO, Y., IKEDA, S., SELDIN, D. C., MERLINI, G., SKINNER, M., KELLY, J.W., DYCK, P. J. & DIFLUNISAL TRIAL, C. (2013). Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial. Journal of the American Medical Association 310(24), 2658-2667.
11. BOLEN, D.W. & ROSE, G. D. (2008). Structure and energetics of the hydrogen-bonded backbone in protein folding. Annual Review of Biochemistry 77, 339-362.
12. BOOTH, P. & CURNOW, P. (2009). Folding scene investigation: Membrane proteins. Current Opinion in Structural Biology 19(1), 8-13.
13. BOOTH, P. J., FLITSCH, S. L., STERN, L. J., GREENHALGH, D. A., KIM, P.S. & KHORANA, H. G. (1995). Intermediates in the folding of the membrane protein bacteriorhodopsin. Nature Structural Biology 2(2), 139-143.
14. BOWIE, J. (2005). Solving the membrane protein folding problem. Nature 438(7068), 581-589.
15. BOWIE, J. U. (2011). Membrane protein folding: How important are hydrogen bonds? Current Opinion in Structural Biology 21 (1), 42-49.
16. BROCKWELL, D. J. & RADFORD, S. E. (2007). Intermediates: Ubiquitous species on folding energy landscapes?. Current Opinion in Structural Biology 17(1), 30-37.
17. BRODSKY, J. L. (2012). Cleaning up: ER-Associated degradation to the rescue. Cell 151(6), 1163-1167.
18. BRODSKY, J.L. & SKACH, W. R. (2011). Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Current Opinion in Cell Biology 23(4), 464-475.
19. BROWN, C. R., HONG-BROWN, L.Q. & WELCH, W. J. (1997). Correcting temperature-sensitive protein folding defects. Journal of Clinical Investigation 99(6), 1432-1444.
20. BROWN, M. F. (2012). Curvature forces in membrane lipid-protein interactions. Biochemistry 51(49), 9782-9795.
21. BUCHBERGER, A., BUKAU, B. & SOMMER, T. (2010). Protein quality control in the cytosol and the endoplasmic reticulum: Brothers in arms. Molecular Cell 40(2), 238-252.
22. BUCK, T.M. & SKACH, W. R. (2005). Differential stability of biogenesis intermediates reveals a common pathway for aquaporin-1 topological maturation. Journal of Biological Chemistry 280(1), 261-269.
23. BURGESS, N., DAO, T., STANLEY, A. & FLEMING, K. (2008). Beta-barrel proteins that reside in the Escherichia coli outer membrane in vivo demonstrate varied folding behavior in vitro. Journal of Biological Chemistry 283(39), 26748-26758.
24. CALAMINI, B., SILVA, M. C., MADOUX, F., HUTT, D. M., KHANNA, S., CHALFANT, M. A., SALDANHA, S. A., HODDER, P., TAIT, B. D., GARZA, D., BALCH, W.E. & MORIMOTO, R. I. (2012). Small-molecule proteostasis regulators for protein conformational diseases. Nature Chemical Biology 8(2), 185-196.
25. CANNON, K.S. & CRESSWELL, P. (2001). Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO Journal 20(10), 2443-2453.
26. CAO, Z. & BOWIE, J. U. (2012). Shifting hydrogen bonds may produce flexible transmembrane helices. Proceedings of the National Academy of Sciences of the United States of America 109(21), 8121-8126.
27. CAO, Z., SCHLEBACH, J., PARK, C. & BOWIE, J. U. (2011). Thermodynamic stability of bacteriorhodopsin mutants measured relative to the bacterioopsin unfolded state. Biochimica et Biophysica Acta 1818(4), 1049-1054.
28. CARLILE, G.W., KEYZERS, R. A., TESKE, K. A., ROBERT, R., WILLIAMS, D. E., LININGTON, R. G., GRAY, C. A., CENTKO, R. M., YAN, L., ANJOS, S. M., SAMPSON, H. M., ZHANG, D., LIAO, J., HANRAHAN, J.W., ANDERSEN, R. J. & THOMAS, D. Y. (2012). Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP. Chemical Biology 19(10), 1288-1299.
29. CESTÈLE, S., SCHIAVON, E., RUSCONI, R., FRANCESCHETTI, S. & MANTEGAZZA, M. (2013). Nonfunctional NaV1 1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects. Proceedings of the National Academy of Sciences of the United States of America 110(43), 17546-17551.
30. CHANG, Y.C. & BOWIE, J. U. (2014). Measuring membrane protein stability under native conditions. Proceedings of the National Academy of Sciences of the United States of America 111(1), 219-224.
31. CHEN, F., DEGNIN, C., LAEDERICH, M., HORTON, W.A. & HRISTOVA, K. (2011). The A391E mutation enhances FGFR3 activation in the absence of ligand. Biochimica et Biophysica Acta 1808(8), 2045-2050.
32. CHEN, M. & ZHANG, J. T. (1999). Topogenesis of cystic fibrosis transmembrane conductance regulator (CFTR): Regulation by the amino terminal transmembrane sequences. Biochemistry 38(17), 5471-5477.
33. CHENG, S. H., GREGORY, R. J., MARSHALL, J., PAUL, S., SOUZA, D.W., WHITE, G. A., O'RIORDAN, C.R. & SMITH, A.E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63(4), 827-834.
34. COHEN, F.E. & KELLY, J.W. (2003). Therapeutic approaches to protein-misfolding diseases. Nature 426(6968), 905-909.
35. COPPINGER, J. A., HUTT, D. M., RAZVI, A., KOULOV, A. V., PANKOW, S., YATES, J. R. III & BALCH, W. E. (2012). A chaperone trap contributes to the onset of cystic fibrosis. PLoS ONE 7(5), e37682.
36. CURNOW, P. & BOOTH, P. (2007). Combined kinetic and thermodynamic analysis of alpha-helical membrane protein unfolding. Proceedings of the National Academy of Sciences of the United States of America 104(48), 18970-18975.
37. CURNOW, P. & BOOTH, P. (2009). The transition state for integral membrane protein folding. Proceedings of the National Academy of Sciences of the United States of America 106(3), 773-778.
38. CURNOW, P. & BOOTH, P. J. (2010). The contribution of a covalently bound cofactor to the folding and thermodynamic stability of an integral membrane protein. Journal of Molecular Biology 403(4), 630-642.
39. CURNOW, P., DI BARTOLO, N. D., MORETON, K. M., AJOJE, O. O., SAGGESE, N.P. & BOOTH, P. J. (2011). Stable folding core in the folding transition state of an alpha-helical integral membrane protein. Proceedings of the National Academy of Sciences of the United States of America 108(34), 14133-14138.
40. CYMER, F. & VON HEIJNE, G. (2013). Cotranslational folding of membrane proteins probed by arrest-peptide-mediated force measurements. Proceedings of the National Academy of Sciences of the United States of America 110(36), 14640-14645.
41. DEDOLA, S., IZUMI, M., MAKIMURA, Y., SEKO, A., KANAMORI, A., SAKONO, M., ITO, Y. & KAJIHARA, Y. (2014). Folding of synthetic homogeneous glycoproteins in the presence of a glycoprotein folding sensor enzyme. Angewandte Chemie International Edition English 53(11), 2883-2887.
42. DENKS, K., VOGT, A., SACHELARU, I., PETRIMAN, N. A., KUDVA, R. & KOCH, H. G. (2014). The Sec translocon mediated protein transport in prokaryotes and eukaryotes. Molecular Membrane Biology 31(2-3), 58-84.
43. DENNING, G. M., ANDERSON, M. P., AMARA, J. F., MARSHALL, J., SMITH, A.E. &WELSH, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358(6389), 761-764.
44. DEVARANENI, P. K., CONTI, B., MATSUMURA, Y., YANG, Z., JOHNSON, A.E. & SKACH, W. R. (2011). Stepwise insertion and inversion of a type II signal anchor sequence in the ribosome-Sec61 translocon complex. Cell 146(1), 134-147.
45. DHAUNCHAK, A.S. & NAVE, K. A. (2007). A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proceedings of the National Academy of Sciences of the United States of America 104(45), 17813-17818.
46. DILL, K.A. & MACCALLUM, J. L. (2012). The protein-folding problem, 50 years on. Science 338(6110), 1042-1046.
47. DILL, K. A., GHOSH, K. & SCHMIT, J. D. (2011). Physical limits of cells and proteomes. Proceedings of the National Academy of Sciences of the United States of America 108(44), 17876-17882.
48. DOURA, A. K., KOBUS, F. J., DUBROVSKY, L., HIBBARD, E. & FLEMING, K. G. (2004). Sequence context modulates the stability of a GxxxG-mediated transmembrane helix-helix dimer. Journal of Molecular Biology 341(4), 991-998.
49. DUTTA, A., KIM, T. Y., MOELLER, M., WU, J., ALEXIEV, U. & KLEIN-SEETHARAMAN, J. (2010). Characterization of membrane protein non-native states. 2. The SDS-unfolded states of rhodopsin. Biochemistry 49(30), 6329-6340.
50. ECKFORD, P. D., RAMJEESINGH, M., MOLINSKI, S., PASYK, S., DEKKERS, J. F., LI, C., AHMADI, S., IP, W., CHUNG, T. E., DU, K., YEGER, H., BEEKMAN, J., GONSKA, T. & BEAR, C. E. (2014). VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface. Chemical Biology, 21(5), 666-678.
51. EGEA, P.F. & STROUD, R.M. (2010). Lateral opening of a translocon upon entry of protein suggests the mechanism of insertion into membranes. Proceedings of the National Academy of Sciences of the United States of America 107(40), 17182-17187.
52. ELETTO, D., MAGANTY, A., ELETTO, D., DERSH, D., MAKAREWICH, C., BISWAS, C., PATON, J. C., PATON, A.W., DOROUDGAR, S., GLEMBOTSKI, C.C. & ARGON, Y. (2012). Limitation of individual folding resources in the ER leads to outcomes distinct from the unfolded protein response. Journal of Cell Science 125(Pt 20), 4865-4875.
53. ELLGAARD, L. & HELENIUS, A. (2003). Quality control in the endoplasmic reticulum. Nature Reviews Molecular Cell Biology 4 (3), 181-191.
54. ENGELMAN, D.M. & STEITZ, T. A. (1981). The spontaneous insertion of proteins into and across membranes: The helical hairpin hypothesis. Cell 23(2), 411-422.
55. ENGELMAN, D. M., CHEN, Y., CHIN, C. N., CURRAN, A. R., DIXON, A. M., DUPUY, A. D., LEE, A. S., LEHNERT, U., MATTHEWS, E. E., RESHETNYAK, Y. K., SENES, A. & POPOT, J. L. (2003). Membrane protein folding: Beyond the two stage model. FEBS Letters 555(1), 122-125.
56. ESCUSA-TORET, S., VONK, W. I. & FRYDMAN, J. (2013). Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress. Nature Cellular Biology 15(10), 1231-1243.
57. FAHAM, S., YANG, D., BARE, E., YOHANNAN, S., WHITELEGGE, J. & BOWIE, J. (2004). Side-chain contributions to membrane protein structure and stability. Journal of Molecular Biology 335(1), 297-305.
58. FAN, J. Q., ISHII, S., ASANO, N. & SUZUKI, Y. (1999). Accelerated transport and maturation of lysosomal alphagalactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nature Medicine 5(1), 112-115.
59. FARINHA, C. M., MATOS, P. & AMARAL, M. D. (2013). Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: Not just from the endoplasmic reticulum to the Golgi. FEBS Journal 280(18), 4396-4406.
60. FEIGE, M. J. & HENDERSHOT, L.M. (2013). Quality control of integral membrane proteins by assembly-dependent membrane integration. Molecular Cell 51(3), 297-309.
61. FICKER, E., OBEJERO-PAZ, C. A., ZHAO, S. & BROWN, A.M. (2002). The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-A-gogo-related gene (HERG) mutations. Journal of Biological Chemistry 277(7), 4989-4998.
62. FINDLAY, H. E., RUTHERFORD, N. G., HENDERSON, P. J. & BOOTH, P. J. (2010). Unfolding free energy of a two-domain transmembrane sugar transport protein. Proceedings of the National Academy of Sciences of the United States of America 107 (43), 18451-18456.
63. FLEMING, K. G. (2002). Standardizing the free energy change of transmembrane helix-helix interactions. Journal of Molecular Biology 323(3), 563-571.
64. FLEMING, K.G. (2014). Energetics of membrane protein folding. Annual Review of Biophysics 43, 233-255.
65. FLEMING, K.G. & ENGELMAN, D.M. (2001). Specificity in transmembrane helix-helix interactions can define a hierarchy of stability for sequence variants. Proceedings of the National Academy of Sciences of the United States of America 98(25), 14340-14344.
66. FLEMING, K. G., ACKERMAN, A.L. & ENGELMAN, D.M. (1997). The effect of point mutations on the free energy of transmembrane alpha-helix dimerization. Journal of Molecular Biolology 272(2), 266-275.
67. FONTANINI, A., CHIES, R., SNAPP, E. L., FERRARINI, M., FABRIZI, G.M. & BRANCOLINI, C. (2005). Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-Tooth 1A Gas3/PMP22 mutants. Journal of Biological Chemistry 280(3), 2378-2387.
68. FORTUN, J., DUNN, W. A., JOY, S., LI, J. & NOTTERPEK, L. (2003). Emerging role for autophagy in the removal of aggresomes in Schwann cells. Journal of Neuroscience 23(33), 10672-10680.
69. FORTUN, J., LI, J., GO, J., FENSTERMAKER, A., FLETCHER, B. S. & NOTTERPEK, L. (2005). Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. Journal of Neurochemistry 92(6), 1531-1541.
70. GAFVELIN, G. & VON HEIJNE, G. (1994). Topological 'frustration' in multispanning E. coli inner membrane proteins. Cell 77(3), 401-412.
71. GAMERDINGER, M., KAYA, A. M., WOLFRUM, U., CLEMENT, A.M. & BEHL, C. (2011). BAG3 mediates chaperone-based aggresome-Targeting and selective autophagy of misfolded proteins. EMBO Reports 12(2), 149-156.
72. GARCIA-MATA, R., BEBOK, Z., SORSCHER, E. J. & SZTUL, E. S. (1999). Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. Journal of Cell Biology 146(6), 1239-1254.
73. GARCIA-MATA, R., GAO, Y. S. & SZTUL, E. (2002). Hassles with taking out the garbage: Aggravating aggresomes. Traffic 3(6), 388-396.
74. GESSMANN, D., CHUNG, Y. H., DANOFF, E. J., PLUMMER, A. M., SANDLIN, C.W., ZACCAI, N.R. & FLEMING, K. G. (2014). Outer membrane beta-barrel protein folding is physically controlled by periplasmic lipid head groups and BamA. Proceedings of the National Academy of Sciences of the United States of America 111(16), 5878-5883.
75. GEVA, Y. & SCHULDINER, M. (2014). The back and forth of cargo exit from the endoplasmic reticulum. Current Biology 24 (3), R130-R136.
76. GHOSH, K. & DILL, K. A. (2009). Computing protein stabilities from their chain lengths. Proceedings of the National Academy of Sciences of the United States of America 106(26), 10649-10654.
77. GHOSH, K. & DILL, K. (2010). Cellular proteomes have broad distributions of protein stability. Biophysical Journal 99(12), 3996-4002.
78. GIDALEVITZ, T., BEN-ZVI, A., HO, K. H., BRIGNULL, H.R. & MORIMOTO, R. I. (2006). Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311(5766), 1471-1474.
79. GIDALEVITZ, T., KIKIS, E.A. & MORIMOTO, R. I. (2010). A cellular perspective on conformational disease: The role of genetic background and proteostasis networks. Current Opinion in Structural Biology 20(1), 23-32.
80. GOLDBERG, A. F., LOEWEN, C. J. & MOLDAY, R. S. (1998). Cysteine residues of photoreceptor peripherin/rds: Role in subunit assembly and autosomal dominant retinitis pigmentosa. Biochemistry 37(2), 680-685.
81. GONG, Q., JONES, M.A. & ZHOU, Z. (2006). Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome. Journal of Biological Chemistry 281(7), 4069-4074.
82. GRATKOWSKI, H., LEAR, J.D. & DEGRADO, W. F. (2001). Polar side chains drive the association of model transmembrane peptides. Proceedings of the National Academy of Sciences of the United States of America 98(3), 880-885.
83. HARRIS, N. J., FINDLAY, H. E., SIMMS, J., LIU, X. & BOOTH, P. J. (2014). Relative domain folding and stability of a membrane transport protein. Journal of Molecular Biology 426(8), 1812-1825.
84. HE, L. & HRISTOVA, K. (2008). Pathogenic activation of receptor tyrosine kinases in mammalian membranes. Journal of Molecular Biology 384(5), 1130-1142.
85. HEBERT, D.N. & MOLINARI, M. (2012). Flagging and docking: Dual roles for N-glycans in protein quality control and cellular proteostasis. Trends in Biochemical Sciences 37(10), 404-410.
86. HEINRICH, S.U. & RAPOPORT, T. A. (2003). Cooperation of transmembrane segments during the integration of a doublespanning protein into the ER membrane. EMBO Journal 22(14), 3654-3663.
87. HEINRICH, S. U., MOTHES, W., BRUNNER, J. & RAPOPORT, T. A. (2000). The Sec61p complex mediates the integration of a membrane protein by allowing lipid partitioning of the transmembrane domain. Cell 102(2), 233-244.
88. HERMANSSON, M. & VON HEIJNE, G. (2003). Inter-helical hydrogen bond formation during membrane protein integration into the ER membrane. Journal of Molecular Biology 334(4), 803-809.
89. HESSA, T., KIM, H., BIHLMAIER, K., LUNDIN, C., BOEKEL, J., ANDERSSON, H., NILSSON, I., WHITE, S.H. & VON HEIJNE, G. (2005). Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature 433(7024), 377-381.
90. HESSA, T., MEINDL-BEINKER, N. M., BERNSEL, A., KIM, H., SATO, Y., LERCH-BADER, M., NILSSON, I., WHITE, S.H. & VON HEIJNE, G. (2007). Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 450(7172), 1026-1030.
91. HONG, H. & BOWIE, J. U. (2011). Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments. Journal of the American Chemical Society 133(29), 11389-11398.
92. HONG, H.&TAMM, L. (2004). Elastic coupling of integral membrane protein stability to lipid bilayer forces. Proceedings of the National Academy of Sciences of the United States of America 101(12), 4065-4070.
93. HONG, H., JOH, N., BOWIE, J. & TAMM, L. (2009). Methods for measuring the thermodynamic stability of membrane proteins. Methods in Enzymology 455, 213-236.
94. HONG, H., BLOIS, T. M., CAO, Z. & BOWIE, J. U. (2010). Method to measure strong protein-protein interactions in lipid bilayers using a steric trap. Proceedings of the National Academy of Sciences of the United States of America 107(46), 19802-19807.
95. HOUCK, S.A. & CYR, D.M. (2012). Mechanisms for quality control of misfolded transmembrane proteins. Biochimica et Biophysica Acta 1818(4), 1108-1114.
96. HUANG, K. S., BAYLEY, H., LIAO, M. J., LONDON, E. & KHORANA, H. G. (1981). Refolding of an integral membrane protein. Denaturation, renaturation, and reconstitution of intact bacteriorhodopsin and two proteolytic fragments. Journal of Biological Chemistry 256(8), 3802-3809.
97. HUYSMANS, G. H., BALDWIN, S. A., BROCKWELL, D. J. & RADFORD, S. E. (2010). The transition state for folding of an outer membrane protein. Proceedings of the National Academy of Sciences of the United States of America 107(9), 4099-4104.
98. HUYSMANS, G. H., RADFORD, S. E., BALDWIN, S.A. & BROCKWELL, D. J. (2012). Malleability of the folding mechanism of the outer membrane protein PagP: Parallel pathways and the effect of membrane elasticity. Journal of Molecular Biology 416 (3), 453-464.
99. HWA, J., REEVES, P. J., KLEIN-SEETHARAMAN, J., DAVIDSON, F. & KHORANA, H. G. (1999). Structure and function in rhodopsin: Further elucidation of the role of the intradiscal cysteines, Cys-110,-185, and-187, in rhodopsin folding and function. Proceedings of the National Academy of Sciences of the United States of America 96(5), 1932-1935.
100. ILLERGARD, K., KAUKO, A. & ELOFSSON, A. (2011). Why are polar residues within the membrane core evolutionary conserved? Proteins 79(1), 79-91.
101. JANOVICK, J. A., STEWART, M. D., JACOB, D., MARTIN, L. D., DENG, J. M., STEWART, C. A., WANG, Y., CORNEA, A., CHAVALI, L., LOPEZ, S., MITALIPOV, S., KANG, E., LEE, H. S., MANNA, P. R., STOCCO, D. M., BEHRINGER, R.R. & CONN, P.M. (2013). Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy. Proceedings of the National Academy of Sciences of the United States of America 110(52), 21030-21035.
102. JASWAL, S. S., SOHL, J. L., DAVIS, J.H. & AGARD, D. A. (2002). Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability. Nature 415(6869), 343-346.
103. JEFFERSON, R. E., BLOIS, T.M. & BOWIE, J. U. (2013). Membrane proteins can have high kinetic stability. Journal of the American Chemical Society 135(40), 15183-15190.
104. JETTEN, A.M. & SUTER, U. (2000). The peripheral myelin protein 22 and epithelial membrane protein family. Progress in Nucleic Acid Research and Molecular Biology 64, 97-129.
105. JOH, N., MIN, A., FAHAM, S., WHITELEGGE, J., YANG, D., WOODS, V. & BOWIE, J. (2008). Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins. Nature 453(7199), 1266-1270.
106. JOH, N. H., OBERAI, A., YANG, D., WHITELEGGE, J.P. & BOWIE, J. U. (2009). Similar energetic contributions of packing in the core of membrane and water-soluble proteins. Journal of the American Chemical Society 131(31), 10846-10847.
107. JOHNSON, A.E. & VAN WAES, M. A. (1999). The translocon: A dynamic gateway at the ER membrane. Annual Review of Cell and Developmental Biology 15, 799-842.
108. JOHNSTON, J. A., WARD, C.L. & KOPITO, R. R. (1998). Aggresomes: A cellular response to misfolded proteins. Journal of Cell Biology 143(7), 1883-1898.
109. JOHNSTON, J. A., ILLING, M.E. & KOPITO, R. R. (2002). Cytoplasmic dynein/dynactin mediates the assembly of aggresomes. Cell Motility and the Cytoskeleton 53(1), 26-38.
110. JUNG, J., COE, H. & MICHALAK, M. (2011). Specialization of endoplasmic reticulum chaperones for the folding and function of myelin glycoproteins P0 and PMP22. FASEB Journal 25(11), 3929-3937.
111. KAGANOVICH, D., KOPITO, R. & FRYDMAN, J. (2008). Misfolded proteins partition between two distinct quality control compartments. Nature 454(7208), 1088-1095.
112. KANEHARA, K., XIE, W. & NG, D. T. (2010). Modularity of the Hrd1 ERAD complex underlies its diverse client range. Journal of Cell Biology 188(5), 707-716.
113. KANKI, T., SAKAGUCHI, M., KITAMURA, A., SATO, T., MIHARA, K. & HAMASAKI, N. (2002). The tenth membrane region of band 3 is initially exposed to the luminal side of the endoplasmic reticulum and then integrated into a partially folded band 3 intermediate. Biochemistry 41(47), 13973-13981.
114. KANNER, E. M., KLEIN, I. K., FRIEDLANDER, M. & SIMON, S.M. (2002). The amino terminus of opsin translocates 'posttranslationally' as efficiently as cotranslationally. Biochemistry 41(24), 7707-7715.
115. KAUKO, A., HEDIN, L. E., THEBAUD, E., CRISTOBAL, S., ELOFSSON, A. & VON HEIJNE, G. (2010). Repositioning of transmembrane alpha-helices during membrane protein folding. Journal of Molecular Biology 397(1), 190-201.
116. KAUSHAL, S. & KHORANA, H. G. (1994). Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33(20), 6121-6128.
117. KAWAGUCHI, Y., KOVACS, J. J., MCLAURIN, A., VANCE, J. M., ITO, A. & YAO, T. P. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6), 727-738.
118. KELLY, J.W. & BALCH, W. E. (2006). The integration of cell and chemical biology in protein folding. Nature Chemical Biology 2(5), 224-227.
119. KHUSHOO, A., YANG, Z., JOHNSON, A.E. & SKACH, W. R. (2011). Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1. Molecular Cell 41(6), 682-692.
120. KIM, B. L., SCHAFER, N.P. & WOLYNES, P. G. (2014). Predictive energy landscapes for folding alpha-helical transmembrane proteins. Proceedings of the National Academy of Sciences of the United States of America 111(30), 11031-11036.
121. KIM, S. J. & SKACH, W. R. (2012). Mechanisms of CFTR folding at the endoplasmic reticulum. Frontiers in Pharmacology 3, 201.
122. KOPITO, R. R. (2000). Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology 10(12), 524-530.
123. KOWALSKI, J. M., PAREKH, R. N., MAO, J. & WITTRUP, K. D. (1998). Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. Journal of Biological Chemistry 273(31), 19453-19458.
124. KOWALSKI, J. M., PAREKH, R.N. & WITTRUP, K. D. (1998). Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 37(5), 1264-1273.
125. KRISHNAMANI, V. & LANYI, J. K. (2011). Structural changes in bacteriorhodopsin during in vitro refolding from a partially denatured state. Biophysical Journal 100(6), 1559-1567.
126. KRISHNAMANI, V., HEGDE, B. G., LANGEN, R. & LANYI, J. K. (2012). Secondary and tertiary structure of bacteriorhodopsin in the SDS denatured state. Biochemistry 51(6), 1051-1060.
127. LAU, F. & BOWIE, J. (1997). A method for assessing the stability of a membrane protein. Biochemistry 36(19), 5884-5892.
128. LEE, M. C., MILLER, E. A., GOLDBERG, J., ORCI, L. & SCHEKMAN, R. (2004). Bi-directional protein transport between the ER and Golgi. Annual Review of Cell and Developmental Biology 20, 87-123.
129. LI, E., YOU, M. & HRISTOVA, K. (2006). FGFR3 dimer stabilization due to a single amino acid pathogenic mutation. Journal of Molecular Biology 356(3), 600-612.
130. LI, E., WIMLEY, W.C. & HRISTOVA, K. (2012). Transmembrane helix dimerization: Beyond the search for sequence motifs. Biochimica et Biophysica Acta 1818(2), 183-193.
131. LI, J., PARKER, B., MARTYN, C., NATARAJAN, C. & GUO, J. (2012). The PMP22 gene and its related diseases. Molecular Neurobiology 47(2), 673-698.
132. LIU, X., GARRIGA, P. & KHORANA, H. G. (1996). Structure and function in rhodopsin: Correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 93(10), 4554-4559.
133. LONDON, E. & KHORANA, H. (1982). Denaturation and renaturation of bacteriorhodopsin in detergents and lipid-detergent mixtures. Journal of Biological Chemistry 257(12), 7003-7011.
134. LU, H. & BOOTH, P. J. (2000). The final stages of folding of the membrane protein bacteriorhodopsin occur by kinetically indistinguishable parallel folding paths that are mediated by pH. Journal of Molecular Biology 299(1), 233-243.
135. LU, W., CHAI, Q., ZHONG, M., YU, L., FANG, J., WANG, T., LI, H., ZHU, H.&WEI, Y. (2012). Assembling of AcrB trimer in cell membrane. Journal of Molecular Biology 423(1), 123-134.
136. LU, Y., XIONG, X., HELM, A., KIMANI, K., BRAGIN, A. & SKACH, W. R. (1998). Co-And posttranslational translocation mechanisms direct cystic fibrosis transmembrane conductance regulator N terminus transmembrane assembly. Journal of Biological Chemistry 273(1), 568-576.
137. LU, Y., TURNBULL, I. R., BRAGIN, A., CARVETH, K., VERKMAN, A. S. & SKACH, W. R. (2000). Reorientation of aquaporin-1 topology during maturation in the endoplasmic reticulum. Molecular Biology of the Cell 11(9), 2973-2985.
138. LUNDBAEK, J. A., ANDERSEN, O. S., WERGE, T. & NIELSEN, C. (2003). Cholesterol-induced protein sorting: An analysis of energetic feasibility. Biophysical Journal 84(3), 2080-2089.
139. MAATTANEN, P., KOZLOV, G., GEHRING, K. & THOMAS, D. Y. (2006). ERp57 and PDI: Multifunctional protein disulfide isomerases with similar domain architectures but differing substrate-partner associations. Biochemistry and Cell Biology 84 (6), 881-889.
140. MACKENZIE, K.R. & FLEMING, K.G. (2008). Association energetics of membrane spanning alpha-helices. Current Opinion in Structural Biology 18(4), 412-419.
141. MARTIN, G. M., CHEN, P. C., DEVARANENI, P. & SHYNG, S. L. (2013). Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels. Frontiers in Physiology 4, 386.
142. MATTHEWS, E. E., ZOONENS, M. & ENGELMAN, D.M. (2006). Dynamic helix interactions in transmembrane signaling. Cell 127(3), 447-450.
143. MEACHAM, G. C., LU, Z., KING, S., SORSCHER, E., TOUSSON, A. & CYR, D.M. (1999). The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO Journal 18(6), 1492-1505.
144. MEINDL-BEINKER, N. M., LUNDIN, C., NILSSON, I., WHITE, S.H. & VON HEIJNE, G. (2006). Asn-And Asp-mediated interactions between transmembrane helices during translocon-mediated membrane protein assembly. EMBO Reports 7(11), 1111-1116.
145. MERULLA, J., FASANA, E., SOLDA, T. & MOLINARI, M. (2013). Specificity and regulation of the endoplasmic reticulum-Associated degradation machinery. Traffic 14(7), 767-777.
146. MICHELSEN, K., YUAN, H. & SCHWAPPACH, B. (2005). Hide and run. Arginine-based endoplasmic-reticulum-sorting motifs in the assembly of heteromultimeric membrane proteins. EMBO Reports 6(8), 717-722.
147. MIYANO, M., AGO, H., SAINO, H., HORI, T. & IDA, K. (2010). Internally bridging water molecule in transmembrane alphahelical kink. Current Opinion in Structural Biology 20(4), 456-463.
148. MOLINARI, M., ERIKSSON, K. K., CALANCA, V., GALLI, C., CRESSWELL, P., MICHALAK, M. & HELENIUS, A. (2004). Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Molecular Cell 13(1), 125-135.
149. MOON, C.P. & FLEMING, K. G. (2011). Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers. Proceedings of the National Academy of Sciences of the United States of America 108(25), 10174-10177.
150. MOON, C. P., KWON, S. & FLEMING, K. G. (2011). Overcoming hysteresis to attain reversible equilibrium folding for outer membrane phospholipase A in phospholipid bilayers. Journal of Molecular Biology 413(2), 484-494.
151. MORELLO, J. P., SALAHPOUR, A., LAPERRIERE, A., BERNIER, V., ARTHUS, M. F., LONERGAN, M., PETAJA-REPO, U., ANGERS, S., MORIN, D., BICHET, D.G. & BOUVIER, M. (2000). Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. Journal of Clinical Investigation 105(7), 887-895.
152. MOSS, K., HELM, A., LU, Y., BRAGIN, A. & SKACH, W. R. (1998). Coupled translocation events generate topological heterogeneity at the endoplasmic reticulum membrane. Molecular Biology of the Cell 9(9), 2681-2697.
153. MU, T.W., ONG, D. S., WANG, Y. J., BALCH, W. E., YATES, J. R. III, SEGATORI, L. & KELLY, J.W. (2008). Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134(5), 769-781.
154. MYERS, J. K., MOBLEY, C.K. & SANDERS, C. R. (2008). The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized. Biochemistry 47(40), 10620-10629.
155. NAEF, R. & SUTER, U. (1999). Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiology of Disease 6(1), 1-14.
156. NAGY, J.K. & SANDERS, C. R. (2002). A critical residue in the folding pathway of an integral membrane protein. Biochemistry 41(29), 9021-9025.
157. NAGY, J.K. & SANDERS, C. R. (2004). Destabilizing mutations promote membrane protein misfolding. Biochemistry 43(1), 19-25.
158. NG, D.P. & DEBER, C.M. (2010). Modulation of the oligomerization of myelin proteolipid protein by transmembrane helix interaction motifs. Biochemistry 49(32), 6896-6902.
159. NG, D. P., POULSEN, B.E. & DEBER, C.M. (2012). Membrane protein misassembly in disease. Biochimica et Biophysica Acta 1818(4), 1115-1122.
160. NOTTERPEK, L., RYAN, M. C., TOBLER, A.R. & SHOOTER, E.M. (1999). PMP22 accumulation in aggresomes: Implications for CMT1A pathology. Neurobiology of Disease 6(5), 450-460.
161. ODOLCZYK, N., FRITSCH, J., NOREZ, C., SERVEL, N., DA CUNHA, M. F., BITAM, S., KUPNIEWSKA, A., WISZNIEWSKI, L., COLAS, J., TARNOWSKI, K., TONDELIER, D., ROLDAN, A., SAUSSEREAU, E. L., MELIN-HESCHEL, P., WIECZOREK, G., LUKACS, G. L., DADLEZ, M., FAURE, G., HERRMANN, H., OLLERO, M., BECQ, F., ZIELENKIEWICZ, P. & EDELMAN, A. (2013). Discovery of novel potent DeltaF508-CFTR correctors that target the nucleotide binding domain. EMBO Molecular Medicine 5(10), 1484-1501.
162. OJEMALM K. HIGUCHI T. JIANG Y. LANGEL U. NILSSON I. WHITE S. H. SUGA H. VON HEIJNE G. 2011 Apolar surface area determines the efficiency of translocon-mediated membrane-protein integration into the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 108 31 E359-E364.
163. OLZMANN, J. A., KOPITO, R.R. & CHRISTIANSON, J. C. (2013). The mammalian endoplasmic reticulum-Associated degradation system. Cold Spring Harbor Perspectives in Biology 5(9), 1-16.
164. ONG, D. S. & KELLY, J.W. (2011). Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases. Current Opinion in Cell Biology 23(2), 231-238.
165. OTERO, J. H., LIZAK, B. & HENDERSHOT, L.M. (2010). Life and death of a BiP substrate. Seminars in Cell and Developmental Biology 21(5), 472-478.
166. OTZEN, D. (2003). Folding of DsbB in mixed micelles: A kinetic analysis of the stability of a bacterial membrane protein. Journal of Molecular Biology 330(4), 641-649.
167. OTZEN, D. E. (2011). Mapping the folding pathway of the transmembrane protein DsbB by protein engineering. Protein Engineering Design and Selection 24(1-2), 139-149.
168. OZCAN, U., YILMAZ, E., OZCAN, L., FURUHASHI, M., VAILLANCOURT, E., SMITH, R. O., GORGUN, C.Z. & HOTAMISLIGIL, G. S. (2006). Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313(5790), 1137-1140.
169. PAREEK, S., NOTTERPEK, L., SNIPES, G. J., NAEF, R., SOSSIN, W., LALIBERT', J., IACAMPO, S., SUTER, U., SHOOTER, E.M. & MURPHY, R. A. (1997). Neurons promote the translocation of peripheral myelin protein 22 into myelin. Journal of Neuroscience 17(20), 7754-7762.
170. PARK, C., ZHOU, S., GILMORE, J. & MARQUSEE, S. (2007). Energetics-based protein profiling on a proteomic scale: Identification of proteins resistant to proteolysis. Journal of Molecular Biology 368(5), 1426-1437.
171. PARTRIDGE, A.W., THERIEN, A.G. & DEBER, C.M. (2004). Missense mutations in transmembrane domains of proteins: Phenotypic propensity of polar residues for human disease. Proteins 54(4), 648-656.
172. PERLMUTTER, D. H. (2002). Chemical chaperones: A pharmacological strategy for disorders of protein folding and trafficking. Pediatric Research 52(6), 832-836.
173. PETAJA-REPO, U. E., HOGUE, M., BHALLA, S., LAPERRIERE, A., MORELLO, J.P. & BOUVIER, M. (2002). Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO Journal 21(7), 1628-1637.
174. PLACONE, J. & HRISTOVA, K. (2012). Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET. PLoS ONE 7(10), e46678.
175. PLAXCO, K.W., SIMONS, K. T., RUCZINSKI, I. & BAKER, D. (2000). Topology, stability, sequence, and length: Defining the determinants of two-state protein folding kinetics. Biochemistry 39(37), 11177-11183.
176. POPOT, J.L. & ENGELMAN, D.M. (1990). Membrane protein folding and oligomerization: The two-stage model. Biochemistry 29(17), 4031-4037.
177. POPOT, J.L. & ENGELMAN, D.M. (2000). Helical membrane protein folding, stability, and evolution. Annual Review of Biochemistry 69, 881-922.
178. POPOT, J. L., TREWHELLA, J. & ENGELMAN, D.M. (1986). Reformation of crystalline purple membrane from purified bacteriorhodopsin fragments. EMBO Journal 5(11), 3039-3044.
179. POWERS, E. T., MORIMOTO, R. I., DILLIN, A., KELLY, J.W. & BALCH, W. E. (2009). Biological and chemical approaches to diseases of proteostasis deficiency. Annual Review of Biochemistry 78, 959-991.
180. QU, B. H., STRICKLAND, E.H. & THOMAS, P. J. (1997). Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. Journal of Biological Chemistry 272(25), 15739-15744.
181. RADER, A. J., ANDERSON, G., ISIN, B., KHORANA, H. G., BAHAR, I. & KLEIN-SEETHARAMAN, J. (2004). Identification of core amino acids stabilizing rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 101(19), 7246-7251.
182. RAJAN, R. S., ILLING, M. E., BENCE, N.F. & KOPITO, R. R. (2001). Specificity in intracellular protein aggregation and inclusion body formation. Proceedings of the National Academy of Sciences of the United States of America 98(23), 13060-13065.
183. RAMSEY, B.W., DAVIES, J., MCELVANEY, N. G., TULLIS, E., BELL, S. C., DREVINEK, P., GRIESE, M., MCKONE, E.F., WAINWRIGHT, C. E., KONSTAN, M.W., MOSS, R., RATJEN, F., SERMET-GAUDELUS, I., ROWE, S. M., DONG, Q., RODRIGUEZ, S., YEN, K., ORDONEZ, C., ELBORN, J.S. & GROUP, V. X. S. (2011). A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. New England Journal of Medicine 365(18), 1663-1672.
184. RILEY, M., WALLACE, B., FLITSCH, S. & BOOTH, P. (1997). Slow alpha helix formation during folding of a membrane protein. Biochemistry 36(1), 192-196.
185. ROBBEN, J. H., SZE, M., KNOERS, N.V. & DEEN, P.M. (2006). Rescue of vasopressin V2 receptor mutants by chemical chaperones: Specificity and mechanism. Molecular Biology of the Cell 17(1), 379-386.
186. ROTH, D.M. & BALCH, W. E. (2011). Modeling general proteostasis: Proteome balance in health and disease. Current Opinion in Cell Biology 23(2), 126-134.
187. ROWE, S.M. & VERKMAN, A. S. (2013). Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harbor Perspectives in Medicine 3(7), 1-15.
188. RYAN, M. C., SHOOTER, E.M. & NOTTERPEK, L. (2002). Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiology of Disease 10(2), 109-118.
189. RYNO, L. M., WISEMAN, R.L. & KELLY, J.W. (2013). Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases. Current Opinion in Chemical Biology 17(3), 346-352.
190. SADLISH, H. & SKACH, W. R. (2004). Biogenesis of CFTR and other polytopic membrane proteins: New roles for the ribosome-Translocon complex. Journal of Membrane Biology 202(3), 115-126.
191. SADLISH, H., PITONZO, D., JOHNSON, A.E. & SKACH, W. R. (2005). Sequential triage of transmembrane segments by Sec61alpha during biogenesis of a native multispanning membrane protein. Nature Structural and Molecular Biology 12 (10), 870-878.
192. SAKAKURA, M., HADZISELIMOVIC, A., WANG, Z., SCHEY, K.L. & SANDERS, C. R. (2011). Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease. Structure 19(8), 1160-1169.
193. SALIBA, R. S., MUNRO, P. M., LUTHERT, P. J. & CHEETHAM, M. E. (2002). The cellular fate of mutant rhodopsin: Quality control, degradation and aggresome formation. Journal of Cell Science 115(Pt 14), 2907-2918.
194. SAMPSON, H. M., ROBERT, R., LIAO, J., MATTHES, E., CARLILE, G.W., HANRAHAN, J.W. & THOMAS, D. Y. (2011). Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. Chemical Biology 18(2), 231-242.
195. SANDERS, C. & MYERS, J. (2004). Disease-related misassembly of membrane proteins. Annual Review of Biophysics and Biomolecular Structure 33, 25-51.
196. SANDERS, C.R. & MITTENDORF, K. F. (2011). Tolerance to changes in membrane lipid composition as a selected trait of membrane proteins. Biochemistry 50(37), 7858-7867.
197. SANDERS, C.R. & NAGY, J. K. (2000). Misfolding of membrane proteins in health and disease: The lady or the tiger? Current Opinion in Structural Biology 10(4), 438-442.
198. SANDERS, C. R., ISMAIL-BEIGI, F. & MCENERY, M.W. (2001). Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40(32), 9453-9459.
199. SATO, B. K., SCHULZ, D., DO, P.H. & HAMPTON, R. Y. (2009). Misfolded membrane proteins are specifically recognized by the transmembrane domain of the Hrd1p ubiquitin ligase. Molecular Cell 34(2), 212-222.
200. SATO, S., WARD, C. L., KROUSE, M. E., WINE, J. J. & KOPITO, R. R. (1996). Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. Journal of Biological Chemistry 271(2), 635-638.
201. SAWKAR, A. R., CHENG, W. C., BEUTLER, E., WONG, C. H., BALCH, W.E. & KELLY, J.W. (2002). Chemical chaperones increase the cellular activity of N370S beta-glucosidase: A therapeutic strategy for Gaucher disease. Proceedings of the National Academy of Sciences of the United States of America 99(24), 15428-15433.
202. SCHLEBACH, J. P., KIM, M. S., JOH, N. H., BOWIE, J.U. & PARK, C. (2011). Probing membrane protein unfolding with pulse proteolysis. Journal of Molecular Biology 406(4), 545-551.
203. SCHLEBACH, J. P., CAO, Z., BOWIE, J.U. & PARK, C. (2012). Revisiting the folding kinetics of bacteriorhodopsin. Protein Science 21(1), 97-106.
204. SCHLEBACH, J. P., PENG, D., KRONCKE, B. M., MITTENDORF, K. F., NARAYAN, M., CARTER, B.D. & SANDERS, C. R. (2013). Reversible folding of human peripheral myelin protein 22, a tetraspan membrane protein. Biochemistry 52(19), 3229-3241.
205. SCHNELL, D. J. & HEBERT, D. N. (2003). Protein translocons: Multifunctional mediators of protein translocation across membranes. Cell 112(4), 491-505.
206. SEHGAL, P., MOGENSEN, J.E. & OTZEN, D. E. (2005). Using micellar mole fractions to assess membrane protein stability in mixed micelles. Biochimica et Biophysica Acta 1716(1), 59-68.
207. SEKIJIMA, Y., WISEMAN, R. L., MATTESON, J., HAMMARSTROM, P., MILLER, S. R., SAWKAR, A. R., BALCH, W.E. & KELLY, J.W. (2005). The biological and chemical basis for tissue-selective amyloid disease. Cell 121(1), 73-85.
208. SELKOE, D. J. (2003). Folding proteins in fatal ways. Nature 426(6968), 900-904.
209. SHEPPARD, D. N., RICH, D. P., OSTEDGAARD, L. S., GREGORY, R. J., SMITH, A.E. &WELSH, M. J. (1993). Mutations in CFTR associated with mild-disease-form Cl-channels with altered pore properties. Nature 362(6416), 160-164.
210. SKACH, W. R., CALAYAG, M.C. & LINGAPPA, V. R. (1993). Evidence for an alternate model of human P-glycoprotein structure and biogenesis. Journal of Biological Chemistry 268(10), 6903-6908.
211. SKACH, W. R., SHI, L. B., CALAYAG, M. C., FRIGERI, A., LINGAPPA, V.R. & VERKMAN, A. S. (1994). Biogenesis and transmembrane topology of the CHIP28 water channel at the endoplasmic reticulum. Journal of Cell Biology 125(4), 803-815.
212. SNAPP, E. L., REINHART, G. A., BOGERT, B. A., LIPPINCOTT-SCHWARTZ, J. & HEGDE, R. S. (2004). The organization of engaged and quiescent translocons in the endoplasmic reticulum of mammalian cells. Journal of Cell Biology 164(7), 997-1007.
213. SONTAG, E. M., VONK, W. I. & FRYDMAN, J. (2014). Sorting out the trash: The spatial nature of eukaryotic protein quality control. Current Opinion in Cell Biology 26C, 139-146.
214. SRINIVASAN, R., HENDERSON, B. J., LESTER, H.A. & RICHARDS, C. I. (2014). Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease. Pharmacological Research 83, 20-29.
215. STANLEY, A. & FLEMING, K. (2008). The process of folding proteins into membranes: Challenges and progress. Archives of Biochemistry and Biophysics 469(1), 46-66.
216. SUN, F., ZHANG, R., GONG, X., GENG, X., DRAIN, P.F. & FRIZZELL, R. A. (2006). Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. Journal of Biological Chemistry 281(48), 36856-36863.
217. SUNG, C. H., SCHNEIDER, B. G., AGARWAL, N., PAPERMASTER, D. S. & NATHANS, J. (1991). Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 88(19), 8840-8844.
218. SUTER, U. & SNIPES, G. J. (1995). Biology and genetics of hereditary motor and sensory neuropathies. Annual Review of Neuroscience 18, 45-75.
219. SUTER, U., MOSKOW, J. J., WELCHER, A. A., SNIPES, G. J., KOSARAS, B., SIDMAN, R. L., BUCHBERG, A.M. & SHOOTER, E.M. (1992). A leucine-To-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proceedings of the National Academy of Sciences of the United States of America 89(10), 4382-4386.
220. SWANTON, E., HIGH, S. & WOODMAN, P. (2003). Role of calnexin in the glycan-independent quality control of proteolipid protein. EMBO Journal 22(12), 2948-2958.
221. SZETO, J., KANIUK, N. A., CANADIEN, V., NISMAN, R., MIZUSHIMA, N., YOSHIMORI, T., BAZETT-JONES, D.P. & BRUMELL, J. H. (2006). ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2(3), 189-199.
222. TAMARAPPOO, B.K. & VERKMAN, A. S. (1998). Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. Journal of Clinical Investigation 101(10), 2257-2267.
223. TAMBORERO, S., VILAR, M., MARTINEZ-GIL, L., JOHNSON, A.E. & MINGARRO, I. (2011). Membrane insertion and topology of the translocating chain-Associating membrane protein (TRAM). Journal of Molecular Biology 406(4), 571-582.
224. TAO, Y.X. & CONN, P.M. (2014). Chaperoning G Protein-coupled receptors: From cell biology to therapeutics. Endocrione Reviews er20131121.
225. TARDIFF, D. F., JUI, N. T., KHURANA, V., TAMBE, M. A., THOMPSON, M. L., CHUNG, C. Y., KAMADURAI, H. B., KIM, H.T., LANCASTER, A. K., CALDWELL, K. A., CALDWELL, G. A., ROCHET, J. C., BUCHWALD, S.L. & LINDQUIST, S. (2013). Yeast reveal a 'druggable' Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science 342(6161), 979-983.
226. TAYLOR, R.C. & DILLIN, A. (2011). Aging as an event of proteostasis collapse. Cold Spring Harbor Perspectives in Biology 3(5), 1-17.
227. TAYLOR, S. C., FERGUSON, A. D., BERGERON, J. J. & THOMAS, D. Y. (2004). The ER protein folding sensor UDP-glucose glycoprotein-glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nature Structural and Molecular Biology 11(2), 128-134.
228. TEASDALE, R.D. & JACKSON, M. R. (1996). Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the Golgi apparatus. Annual Review of Cell and Developmental Biology 12, 27-54.
229. THERIEN, A. G., GRANT, F.E. & DEBER, C.M. (2001). Interhelical hydrogen bonds in the CFTR membrane domain. Nature Structural Biology 8(7), 597-601.
230. TOBLER, A. R., NOTTERPEK, L., NAEF, R., TAYLOR, V., SUTER, U. & SHOOTER, E.M. (1999). Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-Type protein by direct interaction. Journal of Neuroscience 19(6), 2027-2036.
231. TOBLER, A. R., LIU, N., MUELLER, L. & SHOOTER, E.M. (2002). Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proceedings of the National Academy of Sciences of the United States of America 99(1), 483-488.
232. VAN DEN BERG, B., CLEMONS, W. M., COLLINSON, I., MODIS, Y., HARTMANN, E., HARRISON, S.C. & RAPOPORT, T. A. (2004). X-ray structure of a protein-conducting channel. Nature 427(6969), 36-44.
233. VAN GOOR, F., HADIDA, S., GROOTENHUIS, P. D., BURTON, B., CAO, D., NEUBERGER, T., TURNBULL, A., SINGH, A., JOUBRAN, J., HAZLEWOOD, A., ZHOU, J., MCCARTNEY, J., ARUMUGAM, V., DECKER, C., YANG, J., YOUNG, C., OLSON, E. R., WINE, J. J., FRIZZELL, R. A., ASHLOCK, M. & NEGULESCU, P. (2009). Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proceedings of the National Academy of Sciences of the United States of America 106(44), 18825-18830.
234. VAN GOOR, F., HADIDA, S., GROOTENHUIS, P. D., BURTON, B., STACK, J. H., STRALEY, K. S., DECKER, C. J., MILLER, M., MCCARTNEY, J., OLSON, E. R., WINE, J. J., FRIZZELL, R. A., ASHLOCK, M. & NEGULESCU, P. A. (2011). Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proceedings of the National Academy of Sciences of the United States of America 108(46), 18843-18848.
235. VAN MEER, G., VOELKER, D.R. & FEIGENSON, G.W. (2008). Membrane lipids: Where they are and how they behave. Nature Reviews Molecular Cell Biology 9(2), 112-124.
236. VEERAPPAN, A., CYMER, F., KLEIN, N. & SCHNEIDER, D. (2011). The tetrameric a-helical membrane protein GlpF unfolds via a dimeric folding intermediate. Biochemistry 50(47), 10223-10230.
237. VEMBAR, S. S. & BRODSKY, J. L. (2008). One step at a time: Endoplasmic reticulum-Associated degradation. Nature Reviews Molecular Cell Biology 9(12), 944-957.
238. VIRKKI, M. T., AGRAWAL, N., EDSBACKER, E., CRISTOBAL, S., ELOFSSON, A. & KAUKO, A. (2014). Folding of Aquaporin 1: Multiple evidence that helix 3 can shift out of the membrane core. Protein Science 23(7), 981-992.
239. VON HEIJNE, G. (1986). The distribution of positively charged residues in bacterial inner membrane proteins correlates with the trans-membrane topology. EMBO Journal 5(11), 3021-3027.
240. VON HEIJNE, G. (1992). Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. Journal of Molecular Biology 225(2), 487-494.
241. VON HEIJNE, G. (2006). Membrane-protein topology. Nature Reviews Molecular Cell Biology 7(12), 909-918.
242. WANG, X., VENABLE, J., LAPOINTE, P., HUTT, D. M., KOULOV, A. V., COPPINGER, J., GURKAN, C., KELLNER, W., MATTESON, J., PLUTNER, H., RIORDAN, J. R., KELLY, J.W., YATES, J.R. & BALCH, W. E. (2006). Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127(4), 803-815.
243. WARD, C.L. & KOPITO, R. R. (1994). Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-Type and mutant proteins. Journal of Biological Chemistry 269(41), 25710-25718.
244. WARSCHAWSKI, D. E., ARNOLD, A. A., BEAUGRAND, M., GRAVEL, A., CHARTRAND, E. & MARCOTTE, I. (2011). Choosing membrane mimetics for NMR structural studies of transmembrane proteins. Biochimica et Biophysica Acta 1808(8), 1957-1974.
245. WELCH, W. J. & BROWN, C. R. (1996). Influence of molecular and chemical chaperones on protein folding. Cell Stress and Chaperones 1(2), 109-115.
246. WELSH, M. J. & SMITH, A. E. (1993). Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73(7), 1251-1254.
247. WHITE, S. (2009). Biophysical dissection of membrane proteins. Nature 459(7245), 344-346.
248. WHITE, S. H. (2003). Translocons, thermodynamics, and the folding of membrane proteins. FEBS Letters 555(1), 116-121.
249. WHITE, S.H. & VON HEIJNE, G. (2008). How translocons select transmembrane helices. Annual Review of Biophysics 37, 23-42.
250. WIGLEY, W. C., FABUNMI, R. P., LEE, M. G., MARINO, C. R., MUALLEM, S., DEMARTINO, G.N. & THOMAS, P. J. (1999). Dynamic association of proteasomal machinery with the centrosome. Journal of Cell Biology 145(3), 481-490.
251. WIMLEY, W.C. & WHITE, S. H. (1996). Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nature Structural Biology 3(10), 842-848.
252. WISEMAN, R.L. & BALCH, W. E. (2005). A new pharmacology-drugging stressed folding pathways. Trends in Molecular Medicine 11(8), 347-350.
253. WISEMAN, R. L., KOULOV, A., POWERS, E., KELLY, J.W. & BALCH, W. E. (2007). Protein energetics in maturation of the early secretory pathway. Current Opinion in Cell Biology 19(4), 359-367.
254. WISEMAN, R. L., POWERS, E. T., BUXBAUM, J. N., KELLY, J.W. & BALCH, W. E. (2007). An adaptable standard for protein export from the endoplasmic reticulum. Cell 131(4), 809-821.
255. XIA, K., MANNING, M., HESHAM, H., LIN, Q., BYSTROFF, C. & COL'N, W. (2007). Identifying the subproteome of kinetically stable proteins via diagonal 2D SDS/PAGE. Proceedings of the National Academy of Sciences of the United States of America 104 (44), 17329-17334.
256. XIONG, X., BRAGIN, A., WIDDICOMBE, J. H., COHN, J. & SKACH, W. R. (1997). Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. Journal of Clinical Investigation 100(5), 1079-1088.
257. YAMAMOTO, K., FUJII, R., TOYOFUKU, Y., SAITO, T., KOSEKI, H., HSU, V.W. & AOE, T. (2001). The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum. EMBO Journal 20(12), 3082-3091.
258. YOU, M., SPANGLER, J., LI, E., HAN, X., GHOSH, P. & HRISTOVA, K. (2007). Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers. Biochemistry 46(39), 11039-11046.
259. YU, Z., SAWKAR, A.R. & KELLY, J.W. (2007). Pharmacologic chaperoning as a strategy to treat Gaucher disease. FEBS Journal 274(19), 4944-4950.
260. ZHOU, H.X. & CROSS, T. A. (2013). Influences of membrane mimetic environments on membrane protein structures. Annual Review of Biophysics 42, 361-392.
261. ZOCHER, M., ZHANG, C., RASMUSSEN, S. G., KOBILKA, B.K. & MULLER, D. J. (2012). Cholesterol increases kinetic, energetic, and mechanical stability of the human beta2-Adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America 109(50), E3463-E3472.